vimarsana.com

Latest Breaking News On - Werner gladdines - Page 1 : vimarsana.com

Immunic to Participate in Industry and Scientific Conferences in June

/PRNewswire/ Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for.

San diegoUnited statesDen haagZuid hollandWerner gladdinesEdna kaplanJessica breuPaula schwartzInternational conventionImmunic incRx communications groupCommunications of immunicProgram management clinical development operations of immunicExchange commissionContract management groupPrnewswire immunic inc

EQS-News: Immunic AG: Immunic to Participate in Industry and Scientific Conferences in June

Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Scientific Conferences in June 28.05.2024 / 12:30 CET/CEST The issuer is solely responsible

Den haagZuid hollandUnited statesSan diegoJessica breuEdna kaplanWerner gladdinesPaula schwartzContract management groupRx communications groupDistribution servicesImmunic incInternational conventionExchange commissionImmunic inc nasdaqCommunications of immunic

Immunic sets out June conference appearances

Immunic Inc (NASDAQ:IMUX) will be present at two conferences in June. At the BIO International Convention in San Diego, Jessica Breu, VP of Investor.

San diegoUnited statesDen haagZuid hollandWerner gladdinesJessica breuContract management group assembly onProgram management clinical development operationsImmunic incInternational conventionInvestor relationsProgram managementClinical development operationsPharmaceutical contract management group assembly

Immunic, Inc to Participate in Upcoming Investor and Industry Conferences

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesSan diegoComunidad autonoma de catalunaEdna kaplanPaula schwartzJessica breuWerner gladdinesDaniel vittExchange commissionClinical development operations of immunicRx communications groupClinical trial technologyPrnewswire immunic incImmunic incChief executive officerClinical trials europe

DGAP-News: Immunic, Inc to Participate in Upcoming Investor and Industry Conferences

Issuer: Immunic, Inc. / Key word(s): Conference Immunic, Inc. to Participate in Upcoming Investor and Industry Conferences 25.04.2022.

United statesSan diegoComunidad autonoma de catalunaEdna kaplanPaula schwartzJessica breuDaniel vittWerner gladdinesExchange commissionClinical development operations of immunicRx communications groupClinical trial technologyImmunic incUpcoming investorOphthalmology conference daniel vittChief executive officer

vimarsana © 2020. All Rights Reserved.